Suppr超能文献

基于声电微涡旋平台的高通量和剂量控制的大 cargo 细胞内递送。

High-Throughput and Dosage-Controlled Intracellular Delivery of Large Cargos by an Acoustic-Electric Micro-Vortices Platform.

机构信息

Department of Biomedical Engineering, University of California Irvine, Irvine, CA, 92697, USA.

Center for Advanced Design & Manufacturing of Integrated Microfluidics (CADMIM), University of California Irvine, Irvine, CA, 92697, USA.

出版信息

Adv Sci (Weinh). 2022 Jan;9(1):e2102021. doi: 10.1002/advs.202102021. Epub 2021 Oct 29.

Abstract

A high-throughput non-viral intracellular delivery platform is introduced for the transfection of large cargos with dosage-control. This platform, termed Acoustic-Electric Shear Orbiting Poration (AESOP), optimizes the delivery of intended cargo sizes with poration of the cell membranes via mechanical shear followed by the modulated expansion of these nanopores via electric field. Furthermore, AESOP utilizes acoustic microstreaming vortices wherein up to millions of cells are trapped and mixed uniformly with exogenous cargos, enabling the delivery of cargos into cells with targeted dosages. Intracellular delivery of a wide range of molecule sizes (<1 kDa to 2 MDa) with high efficiency (>90%), cell viability (>80%), and uniform dosages (<60% coefficient of variation (CV)) simultaneously into 1 million cells min per single chip is demonstrated. AESOP is successfully applied to two gene editing applications that require the delivery of large plasmids: i) enhanced green fluorescent protein (eGFP) plasmid (6.1 kbp) transfection, and ii) clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9-mediated gene knockout using a 9.3 kbp plasmid DNA encoding Cas9 protein and single guide RNA (sgRNA). Compared to alternative platforms, this platform offers dosage-controlled intracellular delivery of large plasmids simultaneously to large populations of cells while maintaining cell viability at comparable delivery efficiencies.

摘要

本文介绍了一种高通量非病毒细胞内传递平台,可实现大剂量的载药控制转染。该平台称为声电剪切盘旋打孔(AESOP),通过机械剪切对细胞膜进行打孔,随后通过电场调制这些纳米孔的扩张,从而优化了预期载药尺寸的传递。此外,AESOP 利用声微流涡旋,其中多达百万个细胞被捕获并与外源性载药均匀混合,从而能够以靶向剂量将载药递送到细胞内。该平台能够高效(>90%)、高细胞活力(>80%)、均匀剂量(<60%变异系数 (CV)) 地同时将各种分子大小(<1 kDa 至 2 MDa)的货物递送到 100 万个细胞/分钟/单个芯片内。AESOP 成功应用于两种基因编辑应用,需要递送大质粒:i)增强型绿色荧光蛋白 (eGFP) 质粒(6.1 kbp)转染,ii)使用编码 Cas9 蛋白和单指导 RNA (sgRNA) 的 9.3 kbp 质粒 DNA 通过 CRISPR-Cas9 介导的基因敲除。与替代平台相比,该平台可在保持可比转染效率的同时,对大量细胞同时进行大质粒的剂量控制的细胞内传递。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7243/8728830/75d27eeb525d/ADVS-9-2102021-g003.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验